表纸
市场调查报告书
商品编码
951885

全球代谢体学市场:2020年~2024年

Global Metabolomics Market 2020-2024

出版日期: | 出版商: TechNavio (Infiniti Research Ltd.) | 英文 120 Pages | 订单完成后即时交付

价格
  • 全貌
  • 简介
  • 目录
简介

代谢体学市场在2020年~2024年间,预测将成长到15亿4,000万美元,在预测期间内将以12%的年复合成长率推移。在精密医疗领域上代谢体学的利用数增加,早期且正确的诊断需求不断提升推动了该市场的成长。

本报告提供代谢体学市场调查,提供市场概要,市场成长要素及阻碍因素分析,各用途·各地区的市场规模的变化与预测,供应商分析,市场机会等全面性资讯。

目录

摘要整理

市场形势

市场规模

  • 市场定义
  • 市场区隔分析
  • 2019年的市场规模
  • 市场预测:从2019年~2024年的预测

波特的五力分析

各用途市场市场区隔

  • 市场·市场区隔
  • 各用途比较
  • 生物标记与药物研发-市场规模与预测(2019年~2024年)
  • 营养基因学-市场规模与预测(2019年~2024年)
  • 毒性实验-市场规模与预测(2019年~2024年)
  • 各用途的市场机会

客户形势

各地区形势

  • 各地区市场区隔
  • 各地区比较
  • 北美 -市场规模与预测(2019年~2024年)
  • 欧洲-市场规模与预测(2019年~2024年)
  • 亚洲-市场规模与预测(2019年~2024年)
  • 其他地区-市场规模与预测(2019年~2024年)
  • 主要国家
  • 地区的市场机会
  • 交易量成长要素的需求主导成长
  • 市场课题
  • 市场趋势

业者情势

  • 业者情势
  • 创造性破坏状况

供应商分析

  • 交易厂商
  • 供应商的市场定位
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Bruker Corp.
  • Danaher Corp.
  • Human Metabolome Technologies Inc.
  • Metabolomic Technologies Inc.
  • Metabolon Inc.
  • Shimadzu Corp.
  • Thermo Fisher Scientific Inc.
  • Waters Corp.

附录

目录
Product Code: IRTNTR44443

Technavio has been monitoring the metabolomics market and it is poised to grow by $ 1.54 bn during 2020-2024 progressing at a CAGR of 12% during the forecast period. Our reports on metabolomics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increased adoption of metabolomics in the field of precision medicine and rising demand for early and accurate diagnosis. In addition, increased adoption of metabolomics in the field of precision medicine is anticipated to boost the growth of the market as well.

The metabolomics market analysis includes application segment and geographic landscapes

Technavio's ‘metabolomics market ’ is segmented as below:

By Application:

  • Biomarker and drug discovery
  • Nutrigenomics
  • Toxicology testing

By Geographic Landscape:s

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the growing investments by private and government stakeholders as one of the prime reasons driving the metabolomics market growth during the next few years.

"Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our metabolomics market covers the following areas:

  • Metabolomics market sizing
  • Metabolomics market forecast
  • Metabolomics market industry analysis"

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading metabolomics market vendors that include Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corp., Danaher Corp., Human Metabolome Technologies Inc., Metabolomic Technologies Inc., Metabolon Inc. , Shimadzu Corp., Thermo Fisher Scientific Inc., and Waters Corp.. Also, the metabolomics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Application

  • Market segments
  • Comparison by Application
  • Biomarker and drug discovery - Market size and forecast 2019-2024
  • Nutrigenomics - Market size and forecast 2019-2024
  • Toxicology testing - Market size and forecast 2019-2024
  • Market opportunity by Application

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Volume driver-Demand led growth
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Bruker Corp.
  • Danaher Corp.
  • Human Metabolome Technologies Inc.
  • Metabolomic Technologies Inc.
  • Metabolon Inc.
  • Shimadzu Corp.
  • Thermo Fisher Scientific Inc.
  • Waters Corp.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2019 - 2024 ($ million)
  • 13: Global market: Year-over-year growth 2019 - 2024 (%)
  • 14: Five forces analysis 2019 & 2024
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2019
  • 21: Application - Market share 2019-2024 (%)
  • 22: Comparison by Application
  • 23: Biomarker and drug discovery - Market size and forecast 2019-2024 ($ million)
  • 24: Biomarker and drug discovery - Year-over-year growth 2019-2024 (%)
  • 25: Nutrigenomics - Market size and forecast 2019-2024 ($ million)
  • 26: Nutrigenomics - Year-over-year growth 2019-2024 (%)
  • 27: Toxicology testing - Market size and forecast 2019-2024 ($ million)
  • 28: Toxicology testing - Year-over-year growth 2019-2024 (%)
  • 29: Market opportunity by Application
  • 30: Customer landscape
  • 31: Market share by geography 2019-2024 (%)
  • 32: Geographic comparison
  • 33: North America - Market size and forecast 2019-2024 ($ million)
  • 34: North America - Year-over-year growth 2019-2024 (%)
  • 35: Europe - Market size and forecast 2019-2024 ($ million)
  • 36: Europe - Year-over-year growth 2019-2024 (%)
  • 37: Asia - Market size and forecast 2019-2024 ($ million)
  • 38: Asia - Year-over-year growth 2019-2024 (%)
  • 39: ROW - Market size and forecast 2019-2024 ($ million)
  • 40: ROW - Year-over-year growth 2019-2024 (%)
  • 41: Key leading countries
  • 42: Market opportunity by geography ($ million)
  • 43: Impact of drivers and challenges
  • 44: Vendor landscape
  • 45: Landscape disruption
  • 46: Industry risks
  • 47: Vendors covered
  • 48: Market positioning of vendors
  • 49: Agilent Technologies Inc. - Overview
  • 50: Agilent Technologies Inc. - Business segments
  • 51: Agilent Technologies Inc. - Key offerings
  • 52: Agilent Technologies Inc. - Key customers
  • 53: Agilent Technologies Inc. - Segment focus
  • 54: Bio-Rad Laboratories Inc. - Overview
  • 55: Bio-Rad Laboratories Inc. - Business segments
  • 56: Bio-Rad Laboratories Inc. - Key offerings
  • 57: Bio-Rad Laboratories Inc. - Key customers
  • 58: Bio-Rad Laboratories Inc. - Segment focus
  • 59: Bruker Corp. - Overview
  • 60: Bruker Corp. - Business segments
  • 61: Bruker Corp. - Key offerings
  • 62: Bruker Corp. - Key customers
  • 63: Bruker Corp. - Segment focus
  • 64: Danaher Corp. - Overview
  • 65: Danaher Corp. - Business segments
  • 66: Danaher Corp. - Key offerings
  • 67: Danaher Corp. - Key customers
  • 68: Danaher Corp. - Segment focus
  • 69: Human Metabolome Technologies Inc. - Overview
  • 70: Human Metabolome Technologies Inc. - Product and service
  • 71: Human Metabolome Technologies Inc. - Key offerings
  • 72: Human Metabolome Technologies Inc. - Key customers
  • 73: Human Metabolome Technologies Inc. - Segment focus
  • 74: Metabolomic Technologies Inc. - Overview
  • 75: Metabolomic Technologies Inc. - Product and service
  • 76: Metabolomic Technologies Inc. - Key offerings
  • 77: Metabolomic Technologies Inc. - Key customers
  • 78: Metabolomic Technologies Inc. - Segment focus
  • 79: Metabolon Inc. - Overview
  • 80: Metabolon Inc. - Product and service
  • 81: Metabolon Inc. - Key offerings
  • 82: Metabolon Inc. - Key customers
  • 83: Metabolon Inc. - Segment focus
  • 84: Shimadzu Corp. - Overview
  • 85: Shimadzu Corp. - Business segments
  • 86: Shimadzu Corp. - Key offerings
  • 87: Shimadzu Corp. - Key customers
  • 88: Shimadzu Corp. - Segment focus
  • 89: Thermo Fisher Scientific Inc. - Overview
  • 90: Thermo Fisher Scientific Inc. - Business segments
  • 91: Thermo Fisher Scientific Inc. - Key offerings
  • 92: Thermo Fisher Scientific Inc. - Key customers
  • 93: Thermo Fisher Scientific Inc. - Segment focus
  • 94: Waters Corp. - Overview
  • 95: Waters Corp. - Business segments
  • 96: Waters Corp. - Key offerings
  • 97: Waters Corp. - Key customers
  • 98: Waters Corp. - Segment focus
  • 99: Currency conversion rates for US$
  • 100: Research Methodology
  • 101: Validation techniques employed for market sizing
  • 102: Information sources
  • 103: List of abbreviations